STOCK TITAN

Insider plans $1.34M EXEL stock sale on NASDAQ (NASDAQ: EXEL)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A company insider has filed a Form 144 indicating an intent to sell 30,617 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $1,337,035.20. The shares, classified as performance shares, were acquired from the issuer on 02/15/2026, with the same date listed for payment. The approximate sale date is 02/17/2026 on the NASDAQ market. Over the prior three months, Christopher J. Senner sold 34,278 common shares for $1,473,964.28. By signing the notice, the seller represents that they are not aware of undisclosed material adverse information about the issuer.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for EXEL indicate?

The Form 144 shows an insider’s intent to sell 30,617 common shares with an aggregate market value of $1,337,035.20. It is an advance notice for a potential sale, not confirmation that the transaction has already occurred.

How many EXEL shares are planned to be sold and when?

The filing indicates a planned sale of 30,617 common shares, with an approximate sale date of February 17, 2026. The transaction is to be executed through Morgan Stanley Smith Barney LLC on the NASDAQ market.

What type of EXEL securities are involved in this Form 144?

The securities are common stock acquired as performance shares on February 15, 2026 from the issuer. The same date is listed for payment, and the filing describes the nature of payment as not applicable, implying non-cash performance-based acquisition.

What prior EXEL stock sales are disclosed in the Form 144?

The notice reports that Christopher J. Senner sold 34,278 common shares in a prior transaction on February 13, 2026. Those shares generated gross proceeds of $1,473,964.28, covering all relevant sales in the past three months.

Which broker will handle the planned EXEL stock sale?

The planned sale is to be handled by Morgan Stanley Smith Barney LLC, Executive Financial Services, at its New York Plaza office. The shares are intended to be sold on the NASDAQ exchange, according to the details provided in the notice.

What representation does the EXEL insider make by signing Form 144?

By signing, the insider represents they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed. This representation also applies as of any Rule 10b5-1 plan adoption date.
Exelixis Inc

NASDAQ:EXEL

EXEL Rankings

EXEL Latest News

EXEL Latest SEC Filings

EXEL Stock Data

11.47B
253.13M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
ALAMEDA